Reconnecting

The current page stays visible while onset.to reconnects in the background.

2024, An Eventful Trip for MAPS

Open original

The Multidisciplinary Association for Psychedelic Studies (MAPS) reflects on the significant challenges of 2024, particularly following the regulatory rejection of MDMA-assisted therapy for PTSD. While the decision hindered immediate clinical integration, it serves as a call to redouble efforts in rigorous research and public policy engagement. Advancing medical access to psychedelic-assisted therapies requires long-term commitment and resilience. MAPS maintains its focus on establishing legal pathways for therapeutic use, emphasizing the continued importance of public education and grounded advocacy to drive societal change.